Research & Press

At Bodyport, we take heart health seriously and apply the appropriate technological rigor and clinical expertise to ensure our products and services meet industry standards. Real-world evidence is important to us and our partners. And we know it matters to you—see for yourself.

May 25, 2023

Study to Measure Accuracy of Unique Index for Early, Noninvasive Prediction of Worsening Heart Failure

August 09, 2022

Bodyport Receives FDA Clearance for the Bodyport Cardiac Scale

August 02, 2022

Assessing Heart Function and Fluid Status with Cardiac Scales: Interview with John Lipman, CEO, and Corey Centen, Founder, Bodyport

June 23, 2022

Bodyport Announces Appointment of Jim Pursley to Board of Directors

June 23, 2022

Wearables are collecting a flood of data. An ambitious new study of pregnancy aims to prove that’s valuable for health

June 15, 2022

Bodyport Appoints John Lipman as Chief Executive Officer

April 08, 2022

Feasibility of a Cardiac Scale in Measuring Blood Pressure, Journal of Cardiovascular Translational Research, JCTR

March 08, 2022

Outpatient heart failure monitoring with a novel cardiac scale: tracking volume status, Journal of American College of Cardiology, JACC

December 07, 2021

Noninvasive Scale Measurement of Stroke Volume and Cardiac Output Compared With the Direct Fick Method: A Feasibility Study, Journal of American Heart Failure, JAHA

April 13, 2021